The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - OncoMatrix
Leadership - OncoMatrix
Stock and Other Ownership Interests - OncoMatrix
Consulting or Advisory Role - OncoMatrix
Additional prognostic value of OncoMasTR multigene prognostic signature to clinicopathological information in patients with HR-positive, HER2-negative, lymph node-negative breast cancer from the TAILORx Tissue Bank, Ireland.
 
Darran O'Connor
No Relationships to Disclose
 
Catherine Margaret Kelly
No Relationships to Disclose
 
John Crown
Honoraria - Amgen; Boehringer Ingelheim; Eisai; Genomic Health; Pfizer; Puma Biotechnology; Seagen; Vertex
Speakers' Bureau - Eisai; Pfizer
Research Funding - Boehringer Ingelheim (Inst); Eisai (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bayer; MSD; Pfizer; Roche
 
Niamh Russell
No Relationships to Disclose
 
Stephen Barron
Employment - OncoMatrix
 
Tony Loughman
Employment - OncoMatrix
 
Seodhna Lynch
No Relationships to Disclose
 
Anthony O'Grady
No Relationships to Disclose
 
Katherine M Sheehan
No Relationships to Disclose
 
Joanna Fay
No Relationships to Disclose
 
Anurati Saha
No Relationships to Disclose
 
Peter Dynoodt
Employment - OncoMatrix
 
Bozena Fender
Employment - OncoMatrix
 
Chan-Ju Angel Wang
Employment - OncoMatrix
 
Desmond O'Leary
No Relationships to Disclose
 
Adrian P. Bracken
No Relationships to Disclose
 
Arman Rahman
No Relationships to Disclose
 
Claudia Aura Gonzalez
No Relationships to Disclose
 
Nebras Al Attar
No Relationships to Disclose
 
William M. Gallagher
Employment - OncoMark
Leadership - OncoMark
Stock and Other Ownership Interests - OncoMark
Consulting or Advisory Role - Carrick Therapeutics
Research Funding - Carrick Therapeutics
Patents, Royalties, Other Intellectual Property - Two patents which have been licenced to OncoMark Limited
Travel, Accommodations, Expenses - OncoMark